Discover 492 paid clinical trials in Cranston, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 492
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Providence RI, Boston MA, New York NY, Burlington VT,
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Providence RI, New Haven CT, Albany NY, Lebanon NH,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase 1, Phase 2, Recruiting
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Toronto, Sarasota FL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT05765851
Phase 1, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Providence RI, Boston MA, New York NY, Fairfax VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Providence RI, Boston MA, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase 2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Providence RI, Boston MA, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Providence RI, Boston MA, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for
Neoplasms, Child, Adolescent
Location: Providence RI, New York NY, Washington D.C. DC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 1 - 39
Code: NCT05999994
Phase 2, Recruiting
Nebivolol Effects on Endothelial Function and Erectile Function
for
Erectile Dysfunction
Location: Providence RI
Sponsor: Martin M. Miner, MD
Sex: Male
Age: 25 - 65
Code: NCT01885988
Recruiting
Screening Emotions in Adolescents at the Hospital for mTBI
for
Brain Injury Traumatic Mild, Brain Injuries,
Location: Providence RI, Philadelphia PA, Milwaukee WI, Dallas TX,
Sponsor: University of California, Davis
Sex: All
Age: 11 - 17
Code: NCT06370520
Recruiting
Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study
for
Intubation Complication
Location: Providence RI, Charlottesville VA, Akron OH, Atlanta GA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 19
Code: NCT06085326
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors